CF
GSK icon

Cantor Fitzgerald’s GSK GSK Stock Holding History

Cantor Fitzgerald’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Buy
+28,832
New +$1.52M 0.02% 210
2024
Q1 		– Sell
-638,657
Closed -$23.7M – 295
2023
Q4 		$23.7M Buy
638,657
+630,390
+7,625% +$22.6M 4.86% 7
2023
Q3 		$300K Sell
8,267
-117,207
-93% -$4.16M 0.01% 399
2023
Q2 		$4.47M Sell
125,474
-138,527
-52% -$4.97M 0.1% 203
2023
Q1 		$9.39M Buy
+264,001
New +$9.24M 0.2% 172

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cantor Fitzgerald's GSK Position: Q2 2026 in Review

Cantor Fitzgerald opened a new position in GSK (GSK) in Q2 2026: 28,832 shares worth $1.51M. The stake represents 0.02% of the portfolio and ranks #210 among its holdings. This is a return to the name: Cantor Fitzgerald previously reported a position in GSK as recently as Q4 2023.

Cantor Fitzgerald first reported a position in GSK in Q1 2023 and has held it in 5 quarters since. The position peaked at $23.7M in Q4 2023. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cantor Fitzgerald held 28,832 shares of GSK worth $1.51M as of Q2 2026.
  • GSK was a new Cantor Fitzgerald position in Q2 2026.
  • GSK made up 0.02% of Cantor Fitzgerald's portfolio in Q2 2026, its #210 holding.
  • Cantor Fitzgerald first reported a position in GSK in Q1 2023 and has held it in 5 quarters since.
  • Cantor Fitzgerald's GSK position peaked at $23.7M in Q4 2023.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.